Cedars-Sinai receives $10 million for pioneering studies of debilitating digestive tract disease

(Cedars-Sinai Medical Center) Cedars-Sinai investigators in gastroenterology have been awarded $10 million by the National Institutes of Health to conclude a groundbreaking, decades-long investigation of the genetic and immunological causes of inflammatory bowel disease (IBD). This is the longest IBD study of its kind funded by the NIH and the first to explore the genetic makeup of the disease.